## Filing Overview **Filing Date**: August 11, 2022 **Type of Filing**: [[Filing Definitions#Prospectus Supplement|Prospectus Supplement]] **Linked Document**s: - [[8-11-22 10-Q - Quarterly Report]] - [[5-04-22 EFFECT - 333-259797]] - [[5-04-22 EFFECT - 333-257440]] --- ## Notes - This supplement updates the **Prospectus dated May 4, 2022**, forming part of Rocket Lab’s Registration Statements **333-259797** and **333-257440**. - It incorporates information from Rocket Lab’s **Form 10-Q for Q2 2022**, filed on August 11, 2022, covering the quarter ending June 30, 2022. ### Highlights: - **Financial Updates**: - Revenue: **$55.5 million** for Q2 2022. - Net Loss: **$(37.2 million)** for Q2 2022. - Cash and cash equivalents: **$542.1 million** as of June 30, 2022. - **Operational Updates**: - Continued progress with Electron launches. - Updates on the Neutron development program. - **Common Stock**: - Nasdaq symbol: **RKLB**. - Last reported sale price: **$5.79** as of August 10, 2022. This supplement ensures the prospectus remains aligned with the latest financial and operational disclosures, providing investors with current material information. --- ![[4d4ec3fb-d78c-4865-b8c0-1cb720e6b159.pdf]] #SECFiling #424B3